The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- stewart J. Tepper, Dr.
Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barzilai Mc
Ashkelon, Israel
- Hillel Yaffe Medical Center
Hadera, Israel
- Sharei Zedek Mc
Jerusalem, Israel
- Macabi Healtcenter Services
Kfar Saba, Israel
- Laniado Mc
Netanya, Israel
- Macabi Healtcenter Services
Raanana, Israel
- Clinical Research Consortium, An Amr Company
Tempe, Arizona, United States
- Hartford Healthcare Headache Center
Hartford, Connecticut, United States
- Yale School of Medicine
New Haven, Connecticut, United States
- Regeneris Medical
North Attleboro, Massachusetts, United States
- Clinical Research Consortium, An Amr Company
Las Vegas, Nevada, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2018
- Primary completion
- 4 Aug 2020
- Completion
- 4 Aug 2020
- Last update posted
- 22 Sept 2022
- Registered enrollment
- 187
- Registry id
- NCT03631550
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.